# A Study to Measure Serum Periostin, Asthma-Related Biomarkers and Response to Prednisolone in Adult and Adolescent Patients With Severe Oral Corticosteroid-Dependent Asthma

> **NCT01948401** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 54 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** LABA
- **DRUG:** corticosteroids
- **DRUG:** prednisolone

## Key facts

- **NCT ID:** NCT01948401
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01948401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01948401, "A Study to Measure Serum Periostin, Asthma-Related Biomarkers and Response to Prednisolone in Adult and Adolescent Patients With Severe Oral Corticosteroid-Dependent Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01948401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*